These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 29285635)
1. A proposal regarding reporting of in vitro testing results. Smith MA; Houghton P Clin Cancer Res; 2013 Jun; 19(11):2828-33. PubMed ID: 23580781 [TBL] [Abstract][Full Text] [Related]
2. [Experimental histopathological studies on influences of anticancer agents upon the surgical lesions]. OHNO R Kumamoto Igakkai Zasshi; 1962 Apr; 36():387-421. PubMed ID: 14481402 [No Abstract] [Full Text] [Related]
3. Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunities. Rudd SG Cancer Chemother Pharmacol; 2023 Oct; 92(4):241-251. PubMed ID: 37452860 [TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis. Corno C; D'Arcy P; Bagnoli M; Paolini B; Costantino M; Carenini N; Corna E; Alberti P; Mezzanzanica D; Colombo D; Linder S; Arrighetti N; Perego P Front Cell Dev Biol; 2022; 10():1055067. PubMed ID: 36578788 [TBL] [Abstract][Full Text] [Related]
5. 3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment. Franchi-Mendes T; Eduardo R; Domenici G; Brito C Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572836 [TBL] [Abstract][Full Text] [Related]
6. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation. Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907 [TBL] [Abstract][Full Text] [Related]
7. Exposure time versus cytotoxicity for anticancer agents. Evans DM; Fang J; Silvers T; Delosh R; Laudeman J; Ogle C; Reinhart R; Selby M; Bowles L; Connelly J; Harris E; Krushkal J; Rubinstein L; Doroshow JH; Teicher BA Cancer Chemother Pharmacol; 2019 Aug; 84(2):359-371. PubMed ID: 31102023 [TBL] [Abstract][Full Text] [Related]
8. Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells. Shrestha S; Sorolla A; Fromont J; Blancafort P; Flematti GR Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30275391 [TBL] [Abstract][Full Text] [Related]
9. [Preclinical data as basis for the design of clinical studies]. Fichtner I Onkologie; 2008; 31 Suppl 2():34-8. PubMed ID: 18487867 [TBL] [Abstract][Full Text] [Related]
10. Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group. Perego P; Hempel G; Linder S; Bradshaw TD; Larsen AK; Peters GJ; Phillips RM; Cancer Chemother Pharmacol; 2018 Mar; 81(3):427-441. PubMed ID: 29285635 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologically directed strategies in academic anticancer drug discovery based on the European NCI compounds initiative. Hendriks HR; Govaerts AS; Fichtner I; Burtles S; Westwell AD; Peters GJ Br J Cancer; 2017 Jul; 117(2):195-202. PubMed ID: 28609434 [TBL] [Abstract][Full Text] [Related]
12. A Brief Guide to Performing Pharmacological Studies Capula M; Corno C; El Hassouni B; Li Petri G; Aranđelović S; Anticancer Res; 2019 Jul; 39(7):3413-3418. PubMed ID: 31262863 [TBL] [Abstract][Full Text] [Related]
13. In vitro assays and techniques utilized in anticancer drug discovery. Ediriweera MK; Tennekoon KH; Samarakoon SR J Appl Toxicol; 2019 Jan; 39(1):38-71. PubMed ID: 30073673 [TBL] [Abstract][Full Text] [Related]
14. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking Jo Y; Choi N; Kim K; Koo HJ; Choi J; Kim HN Theranostics; 2018; 8(19):5259-5275. PubMed ID: 30555545 [TBL] [Abstract][Full Text] [Related]